Axios on MSN

FDA effort aims to speed up drug development

The Food and Drug Administration is launching a pilot program intended to speed up the process of bringing new drug ...
Axios on MSN

AI is not yet driving drug development

Curing disease is one of AI's most tantalizing use cases, fetching billions of VC dollars, but thus far it's generated more ...
The Scientist

A New Course Bridges the Gap Between Discovery and Drug Development

The initiative combines coursework, networking, and a task force to provide scientists with real-world knowledge on drug ...
investors

Making Drugs With AI: Biopharma Giants Gear Up For New Arena

ChatGPT will see you now. Artificial intelligence isn't quite that ubiquitous yet in hospitals or biopharma labs. Chatbots from OpenAI, Anthropic and Alphabet (GOOGL) aren't actively diagnosing ...
RAPS

FDA review details use of manufacturing process models in drug applications

Drug manufacturing process models represent a "growing area" of scientific development and have been utilized in new drug applications (NDAs), biologics license applications (BLAs), and supplements to ...